Position in LLY
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$3,743,421
+$639,198 QoQ
Shares Held
3,121
-7.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
#1,948
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 43%
Shared 0%
None 57%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HOWLAND CAPITAL MANAGEMENT LLC holds $45,192,590 across 9 Drug Manufacturers - General names. LLY ranks #4 (8.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
87,734 | $22,281,803 | |
| 2 | ABBV |
AbbVie Inc.
|
29,636 | $7,457,603 | |
| 3 | MRK |
Merck & Co., Inc.
|
45,824 | $5,888,384 | |
| 4 | LLY |
ELI LILLY & Co
This page
|
3,121 | $3,743,421 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
11,420 | $1,442,802 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
22,408 | $1,291,148 | |
| 7 | AMGN |
Amgen Inc
|
3,560 | $1,289,147 | |
| 8 | PFE |
Pfizer Inc
|
51,607 | $1,242,696 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,743,421 | 3,121 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $3,104,223 | 3,375 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $3,552,892 | 3,306 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,314,942 | 3,034 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $2,475,007 | 3,175 | Shares | Sole | 2025-08-15 | |
| 2025-03-31 | $2,814,701 | 3,408 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $2,766,848 | 3,584 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $3,401,123 | 3,839 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $4,103,182 | 4,532 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $3,586,395 | 4,610 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $2,834,157 | 4,862 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $2,862,902 | 5,330 | Shares | Sole | 2023-10-17 | |
| 2023-06-30 | $2,731,808 | 5,825 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $1,998,704 | 5,820 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $2,417,104 | 6,607 | Shares | Sole | 2023-01-30 | |
| 2022-09-30 | $2,244,049 | 6,940 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $1,910,038 | 5,891 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $1,285,228 | 4,488 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $1,192,717 | 4,318 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $991,897 | 4,293 | Shares | Sole | 2021-10-25 | |
| 2021-06-30 | $985,329 | 4,293 | Shares | Sole | 2021-07-28 | |
| 2021-03-31 | $802,018 | 4,293 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $685,996 | 4,063 | Shares | Sole | 2021-01-26 | |
| 2020-09-30 | $620,943 | 4,195 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $693,660 | 4,225 | Shares | Sole | 2020-07-15 | |
| 2020-03-31 | $586,092 | 4,225 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||